Gillian Gadsby

Medical Negligence Solicitor, Co-founder and Managing Partner

 

“When you win a case for someone, you can almost see the weight that has been lifted off their shoulders. The compensation doesn’t undo the damage but it does mean that they have one less thing to worry about as they get on with their lives.”

 

 

 

 

 

 

Qualifications:

1986 – LLB (Hons) University of East Anglia
1989 – Qualified as a solicitor

 

Professional memberships

  • Association of Personal Injury Lawyers (APIL) – Senior Litigator
  • Law Society’s Clinical Negligence Accreditation Scheme
  • AvMA Specialist Clinical Negligence Solicitors Panel
  • AvMA Legal Support Group
  • American Association for Justice

 

Profile:

Gillian Gadsby has specialised exclusively in medical negligence litigation since she qualified as a solicitor in 1989.  Following her articles at Hilliard and Ward (later to be Gepp and Sons), she became increasingly involved in helping medical negligence specialist Roger Wicks to develop the firm’s clinical negligence department. Inspired by some of the pioneering work happening in this area in America during the early 1990’s, she co-founded Gadsby Wicks with Roger Wicks in 1993 and is the firm’s Managing Partner.

Gillian plays piano and guitar and is a keen cyclist. She completed the London to Paris Cycle Ride and has also taken part in the MoonWalk power walking fundraising challenge for breast cancer awareness.

 

Career highlight:

Deciding to become a specialist in medical negligence litigation. Because it requires knowledge of the law and medicine, it is intellectually stimulating and the results of your work can change someone’s life forever. 

 

See below for a selection of cases where Gillian has helped patients and their families make a successful claim for compensation

  • Failure to diagnose tear in aorta, leading to death – £165,000
  • Delayed diagnosis of ventricular failure and coronary artery atheroma – £47,500
  • Cerebral Palsy from birth asphyxia – £2,679,551.40 (lump sum equivalent)
  • Genetic defect undiagnosed because of inadequate antenatal screening – £3,249,500
  • Death following delays in diagnosis of lung cancer – £275,000

 

Gadsby Wicks